Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1173)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,796
Price
$564.53
Total Value
$1.01M
Shares Held After
45,703
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,316
Price
$563.49
Total Value
$741.56K
Shares Held After
47,499
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
878
Price
$562.37
Total Value
$493.76K
Shares Held After
48,815
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$561.21
Total Value
$179.59K
Shares Held After
49,693
% of Holdings
0.6%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
29,404
Price
$0.28
Total Value
$8.23K
Shares Held After
88,377
% of Holdings
25.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.02
Total Value
$267.22K
Shares Held After
382,132
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
PATUSKY CHRISTOPHER — Director
Shares
2,910
Price
$569.00
Total Value
$1.66M
Shares Held After
1,490
% of Holdings
66.1%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
280,381
Price
$3.50
Total Value
$982.03K
Shares Held After
12,395,081
% of Holdings
2.3%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
15,148
Price
$19.19
Total Value
$290.69K
Shares Held After
1,270,556
% of Holdings
1.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
377
Price
$19.19
Total Value
$7.23K
Shares Held After
11,286
% of Holdings
3.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
38,322
Price
$19.19
Total Value
$735.40K
Shares Held After
5,221,857
% of Holdings
0.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
19,261
Price
$19.19
Total Value
$369.62K
Shares Held After
1,719,356
% of Holdings
1.1%
Opus Genetics, Inc. (IRD)
Magrath George — Director
Shares
9,511
Price
$5.22
Total Value
$49.65K
Shares Held After
1,741,344
% of Holdings
0.5%
Opus Genetics, Inc. (IRD)
Jayagopal Ashwath — Chief Scientific & Dev. Ofc.
Shares
7,542
Price
$5.19
Total Value
$39.16K
Shares Held After
509,233
% of Holdings
1.5%
Opus Genetics, Inc. (IRD)
YERXA BENJAMIN R — Director
Shares
7,470
Price
$5.24
Total Value
$39.12K
Shares Held After
711,535
% of Holdings
1.0%
Opus Genetics, Inc. (IRD)
Gagnon Robert E. — Chief Financial Officer
Shares
7,842
Price
$5.18
Total Value
$40.66K
Shares Held After
592,158
% of Holdings
1.3%
Opus Genetics, Inc. (IRD)
SCHACHLE JOSEPH K — Chief Operating Officer
Shares
4,697
Price
$5.22
Total Value
$24.52K
Shares Held After
296,084
% of Holdings
1.6%
Opus Genetics, Inc. (IRD)
Zaremba Rabourn Amy — Head of Fin. Quality Assurance
Shares
1,641
Price
$5.20
Total Value
$8.54K
Shares Held After
188,671
% of Holdings
0.9%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
3,811
Price
$0.29
Total Value
$1.11K
Shares Held After
117,781
% of Holdings
3.1%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
10,000
Price
$75.00
Total Value
$750.00K
Shares Held After
226,958
% of Holdings
4.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Neman-Ebrahim Yousha — Chief Clinical Officer
Shares
500
Price
$4.88
Total Value
$2.44K
Shares Held After
134,760
% of Holdings
0.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.74
Total Value
$261.88K
Shares Held After
386,470
% of Holdings
4.7%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
2,754
Price
$29.62
Total Value
$81.57K
Shares Held After
251,685
% of Holdings
1.1%
Immunovant, Inc. (IMVT)
Girao Tiago — Chief Financial Officer
Shares
25,760
Price
$29.62
Total Value
$763.01K
Shares Held After
247,596
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$576.33
Total Value
$207.48K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
143
Price
$575.26
Total Value
$82.26K
Shares Held After
40,873
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
521
Price
$574.71
Total Value
$299.42K
Shares Held After
41,016
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
567
Price
$573.38
Total Value
$325.11K
Shares Held After
41,537
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,688
Price
$572.60
Total Value
$2.11M
Shares Held After
42,104
% of Holdings
8.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,921
Price
$571.59
Total Value
$1.67M
Shares Held After
45,792
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,055
Price
$570.76
Total Value
$602.16K
Shares Held After
48,713
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
245
Price
$569.62
Total Value
$139.56K
Shares Held After
49,768
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
21
Price
$169.56
Total Value
$3.56K
Shares Held After
9,666
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
54
Price
$168.43
Total Value
$9.10K
Shares Held After
9,687
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
373
Price
$167.37
Total Value
$62.43K
Shares Held After
9,741
% of Holdings
3.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
127
Price
$166.56
Total Value
$21.15K
Shares Held After
10,114
% of Holdings
1.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
158
Price
$165.38
Total Value
$26.13K
Shares Held After
10,241
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
267
Price
$164.47
Total Value
$43.91K
Shares Held After
10,399
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$576.62
Total Value
$69.19K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
535
Price
$574.79
Total Value
$307.51K
Shares Held After
19,360
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
321
Price
$573.51
Total Value
$184.10K
Shares Held After
19,895
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,976
Price
$572.66
Total Value
$2.28M
Shares Held After
20,216
% of Holdings
16.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,325
Price
$571.64
Total Value
$1.90M
Shares Held After
24,192
% of Holdings
12.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,079
Price
$570.82
Total Value
$615.91K
Shares Held After
27,517
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$569.63
Total Value
$159.50K
Shares Held After
28,596
% of Holdings
1.0%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
388,067
% of Holdings
0.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
56,450
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
156,869
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
66,083
% of Holdings
0.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.90
Total Value
$49.00K
Shares Held After
3,052,000
% of Holdings
0.3%
Showing 151–200 of 1173 transactions (page 4 of 24)